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Interaction of arginine vasopressin and angiotensin II on Ca in
vascular smooth muscle cells. The non-osmotic release of arginine
vasopressin (AVP) is associated with the concomitant activation of the
renin-angiotensin and sympathetic nervous systems. In vivo studies
suggest that a positive interaction may occur between AVP and
angiotensin II (Ang II), and other Ca2 mobilizing hormones. In the
present study, the cellular mechanisms of this interaction between AVP
and Ang II in vascular smooth muscle cell (VSMC) were examined.
These results support the existence of a positive interaction between
AVP and Ang II on Ca2 mobilization in VSMC. In fact, the challenge
of VSMC with combined AVP and Ang II, in a range from 5 X lOIs to
10—8 M, enhanced cytosolic free Ca2 ([Ca2]1) and 43Ca2 efflux in a
more than additive manner. This potentiation, which was not dependent
of the presence of extracellular calcium, correlated with an increased
VSMC shape change, Moreover, the combination of subthreshold
doses of AVP and Ang II (5 x lO" M), which do not release Ca2
alone, evoked a Ca2 mobilizing response. A subthreshold dose of Ang
II also shifted to the left the concentration-response curve of the
AVP-mediated 45Ca2 efflux. Since there were no changes in receptor
binding of either hormone by the other hormone and the interaction of
the two hormones on the production of inositol phosphatides was
additive, the AVP and All positive interaction on Ca2 mobilization on
VSMC may occur at the level of the intracellular Ca2-releasing
mechanism itself. Such an interaction can occur at hormone concen-
trations below the Ca2 release threshold and may explain an increased
functional response to the combination of pressor hormones compared
to that of each hormone alone.
A series of studies both in humans and experimental animals
have demonstrated that the non-osmotic release of AVP is
accompanied in virtually every circumstance by a simultaneous
activation of the renin-angiotensin and sympathetic nervous
systems [1]. Additionally, in various pathological circum-
stances accompanied by alterations of the vascular tone, such
as DOC-salt hypertension [2], renovascular hypertension [3],
ganglionic blockade [4], adrenal insufficiency [5], and dehydra-
tion [6], cooperation between the pressor systems is critical in
maintaining cardiovascular homeostasis.
In the conscious rat, simultaneous infusions of AVP, Ang II,
and norepinephrine (NE) enhance the pressor response of one
another, as well as convert subpressor doses of these hormones
to pressor doses [7]. Similar positive interactions have been
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observed between a-l-adrenergic and histaminergic contraction
in isolated vessels [8]. Furthermore, the effect of AVP on
vascular tone has also been shown to be increased by the
influence of Ang II or the adrenergic system [9]. However, the
subject of the pressor hormone interaction in in vivo circum-
stances is not yet completely elucidated, and controversial
results have been published in different animal models [10, 11].
In recent years, studies on the post-receptor events of
hormone-mediated cellular activation have provided new in-
sights on the mechanisms involved in smooth muscle contrac-
tion [12—16]. The contractile cell's response to pressor hor-
mones seems to involve intracellular mechanisms which are, at
least in part, similar for AVP, Ang II, and NE [12—16]. The first,
rapid phase of cell contraction is mainly due to the transient
increase in [Ca2]1 by release of Ca2 from an intracellular
store, namely the endoplasmic reticulum (ER) [12—16]. The
elevated [Ca2]1 triggers the activation of the actin-myosin
system and rapidly returns to near baseline [12—16]. Also, the
simultaneous activation of protein kinase C induces the phos-
phorylation of specific subclasses of proteins involved, among
other functions, in the maintenance of sustained contraction
[14]. Interactions between pressor hormones may therefore
occur at any level of this process and may result in cooperative
or competitive effects between the hormones.
Since the only available information on this subject of pressor
hormone interaction comes from whole animal or isolated
vessel studies [7—11], the present study was designed to exam-
ine the interactions between pressor hormones at the cellular
level, using cultured VSMC. Such an approach allows the
elimination of other potentially interacting mechanisms that are
present in in vivo studies, such as endothelium- and nervous
system-mediated responses; the influence of circulating hor-
mones other than those used in the experiments is also ex-
cluded. The present study involved the assessment of the
interaction of two pressor hormones, AVP and Ang II, on
VSMC Ca2 mobilization. After a positive interaction of AVP
and Ang II on [Ca211 and 45Ca2 effiux was found, the
functional significance of such an interaction was explored by
studying VSMC shape change. Finally, receptor binding and
inositol phosphates production were studied to further clarify
the mechanism of the positive AVP and Ang II interaction.
Threshold and subthreshold doses were used in the experi-
ments, in an effort to approximate conditions in different
physiological and pathological circumstances.
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Methods
Cell culture
Rat aortic smooth muscle cells were isolated using a modifi-
cation [17, 181 of the technique described by Chamley, Camp-
bell and McConnel [19]. Briefly, rat thoracic aortas were
dissected and minced under sterile conditions and incubated in
Eagle's minimum essential medium (MEM) containing 2 mg/mI
collagenase (Cooper Biomedical) (7.5 ml, 37°C, 2.5 to 3.0 hr).
The freshly isolated cells were resuspended in Eagle's MEM
containing 1 M glutamine, 100 U/mI penicillin G, 100 /Lg/ml
streptomycin, and 10% fetal bovine serum (FBS). Cells were
plated in 35 x 10mm culture dishes at a density of 2 x i05 cells
per 1.5 ml of culture medium. For fura2 experiments, cells were
grown on round glass 13 mm diameter coverslips.
Cultures were incubated at 37°C in a humidified atmosphere
of 95% air and 5% CO2. 45Ca2 efflux and fura2 experiments
were performed between days 14 and 21 when cells formed a
confluent monolayer with a density of approximately 1.5 to 2 x
106 cells per dish. All the experiments except receptor binding
were done in primary cultured cells. For the receptor binding
studies, cells were lifted from the culture dishes by Trypsin-
EDTA (0.25 to 0.1%) treatment and subcultured. In order to
obtain an adequate number of confluent cells, the cells used for
AVP or Ang II binding were between third and fifth passages.
Shape change experiments were carried out at three to five days
after cells plating for primary culture. Identity of cells was
confirmed by electron microscopy and viability was higher than
95%, as judged by Trypan blue exclusion.
Measurement of intracellular free Ca2
As described [17, 18], the monolayers on coverslips were
incubated with MEM containing no FBS and with 4 jM fura2
AM for 60 minutes at 37°C. The monolayers were then washed
three times with MEM containing no fura2 and incubated for
another 15 minutes at 37°C to allow any non-hydrolized fura2 to
diffuse from the cells. Before measurements were made, coy-
erslips were rinsed again with physiological saline solution
(PSS) (140 mrt NaCl, 4,6 m KCI, 1.0 mM MgCI2, 2.0 mM
CaC12, 10 m glucose, 10 mM HEPES, pH 7.4). Fluorescence
was measured at 37°C using a fluorescence spectrophotometer
equipped with a thermostatically controlled cuvette holder
(Perkin-Elmer 650-lOS, Norwalk, Connecticut, USA) at an
emission wavelength of 500 nm. Excitation wavelengths of 342
and 380 nm were chosen to monitor the Ca2-induced shift in
fura2 fluorescence, as determined in previous calibrations.
Digitonin and EGTA were used for obtaining Rmax and Rmjn in
each individual experiment [17, 18]. Autofluorescence was
measured in similar cells which had not been loaded with fura2,
and was below 10% of the total fluorescence of fura2 loaded
cells in all of the experiments. No changes in autofluorescence
were detected after the addition of the hormones. Using a
fluorescence microscope (Dialux 20, Leitz, FRG), more than
95% of the VSMC appeared loaded with fura2 in an homoge-
neous pattern, suggesting a cytosolic distribution of the dye.
[Ca2]1 was calculated by the formula used by Grynkiewicz,
Poenie and Tsien [20]. Peak [Ca2] was used for the purpose of
calculations.
Determination of 45Ca2 efflux
45Ca2 efflux was studied by a method similar to that previ-
ously described [17, 181. The culture medium was removed by
aspiration and cell monolayers were rinsed twice with 1 ml PSS
and loaded with 45Ca2 (8 Ci in I ml PSS, 37°C, 3 hr). Then the
cultures were rapidly rinsed ten times (60 sec total) with 1 ml
PSS and 1 ml of PSS was added. The medium was removed and
replaced at each minute with 1 ml of PSS, from one to six
minutes. Samples from each interval were placed into vials for
liquid scintillation counting (Tricarb 460C, Packard Instru-
ments, Downers Grove, Illinois, USA). Hormones were added
at six minutes of the time course of 45Ca2 efflux, and one
minute samples collected for five additional minutes. At 10
minutes, ionomycin (106 M, 1 ml) was added and a one minute
sample collected. Intracellular radioactivity was extracted with
1 ml sodium dodecyl sulfate (SDS) alkaline solution (0.1% SDS,
2% Na2CO3, 0,1 N NaOH). Counts corresponding to basal
45Ca2 release were subtracted and results were calculated as
percent of the total 45Ca2 counts released from the cells in the
first 120 seconds after the addition of the hormone. 45Ca2
release is directly proportional to the [Ca2]1 transient during
the first two minutes after the challenge with the agonists (1O—
AVP, r 0.938, iO M Ang II, r = 0.849, N = 10, P <
0.001).
In both fura2 and 45Ca2 efflux experiments, doses of AVP
and Ang II from 10" to l0_6 M were used for cell stimulation
as detailed in the Results section. In previous experiments with
both AVP and Ang II, 10'° and 10_6 M concentrations had
been established as the threshold and maximal concentrations,
respectively [data not shown, Ref. 17]. Experiments in medium
without Ca2 plus EGTA 0.5 m were also performed to study
the effect of extracellular Ca2 on the interaction of AVP and
Ang II. In the latter experiments, the no-Ca2/EGTA medium
was added for no more than two minutes before the hormonal
agonist, to avoid cellular Ca2 depletion. No alterations in cell
viability or cell attachment to the culture surface were detected
after two minutes in the presence of 0.5 m EGTA medium.
Cell shape change studies
The functional response of VSMC was evaluated as the cell
shape change by using a phase contrast microscope (Carl Zeiss,
1M35, Oberkochen, FRG) with a computerized scanning device
(Zidas, Carl Zeiss) and printer [17]. The VSMC shape change is
mostly due to cell contraction, which causes a significant
reduction in size. However, changes in the organization of the
cytoskeleton, as well as variations in cell volume secondary to
activation of ion transport mechanisms are probably also im-
portant factors of the shape changes. At the time of the
experiment, culture medium was aspirated and cells were
washed twice with PSS. The cells were then incubated at room
temperature with PSS (37°C) in the presence of different con-
centrations of the hormones, and the shape change was evalu-
ated by measuring the area of the cells. The magnitude of the
shape change response was determined by comparing groups of
6 to 12 cells before and after 20 minutes of the addition of the
hormone. Several aspects were considered to insure the reli-
ability of the measurements: 1) the measurements were ob-
tained by triplicate and the mean value of one cell was used for
comparison; 2) all the groups of measurements with a standard
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deviation higher than 10%, respectively, to the mean value were
discarded; and 3) since spontaneous change of the area of some
cells of 5% or less were occasionally observed, only reductions
of 15% or more of the area of the cells were considered as
significant.
Photographs of all the cellular groups before and after the
hormone challenge were taken for planimetric measurement
and the results compared with those of digital computerized
planimetry. No significant discrepancies were found between
the results obtained by the two methods. In the experiments
using combinations, both hormones were added simulta-
neously.
Receptor binding studies
The experiments examining AVP and Ang II binding to
VSMC were carried out in confluent monolayer culture VSMC
on 35 x 10 mm plastic dishes. Cells were rinsed twice with
binding buffer (25 mrvi HEPES, 119.2 mti NaCI, 3.0 ma'i KCI,
1.2 msi MgSO4, 1.0 mM CaCl2; 1.2 mM KH2PO4, 1.0 mM
glucose, 0.1% BSA, pH 7.4). The dishes were incubated at 4°C
for 60 minutes with buffer and effectors and 3H AVP (2 x i0
M). At the end of the incubation, all dishes were rinsed four
times with ice-cold buffer. The cells were lifted up from dishes
with 0.1% SDS + 0.1 N NaOH, to use for scintillation counting
and protein determinations. Non-specific binding was deter-
mined by the same incubation procedure in the presence of 1 x
iO M AVP. All of the determinations were done in triplicate
samples. The Ang II binding experiments were performed in
similar conditions as AVP binding, except that the composition
of the binding buffer was 100 mrvi NaCI, 50 ma'i Tris-HCI, 10 mM
KC1, 5 mi MgCl2, supplemented with 0.5 mg/mI Bacitracin and
0.25 BSA, pH 7.4. Fifty to 100 fmol of 125Ang II were added to
each well. Binding studies were performed at 4°C for 90
minutes. Specific binding was defined as total binding minus
non-specific binding (in the presence of 1 tM Ang II). The
experiments compared binding of the labeled hormone in the
absence or in the presence of the other unlabeled hormone,
such as 3H AVP alone versus 3H AVP + unlabeled Ang II or
'25Ang II alone versus 125Ang II + unlabeled AVP.
Measurement of inositol phosphates
Measurement of the intracellular levels of inositol phosphates
were performed as described [17, 181. After cells were grown to
confluence, the culture media of each dish was replaced with 1
ml of inositol-free medium containing 10 pCi of myo-
2[3Hjinositol (specific activity 16.3 Ci/mmol), and the cells were
incubated for 24 hours. It has been previously shown that
steady state labeling occurs by 24 hours. At the time of the
experiment, culture media were aspirated and replaced with 500
pildish of 37°C PSS containing 108 or l0— M AVP. The
reaction was stopped after 30 seconds using 500 p1 of ice-cold
trichloroacetic acid (20% solution). Cells were scraped using an
Eppendorf pipette tip and aliquots were taken for protein
determination.
The samples were centrifuged at 1,000 x g for 10 minutes.
The supernatant, containing inositol phosphates, was washed
three times with an equal volume of ether and stored at —20°C
until analysis, which was performed during the same week of
the extraction. At the time of the analysis, the water-soluble
fraction was thawed and brought to pH 6.0 using Tris-base (50
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Fig. 1. Positive interaction between arginine vasopressin (A VP) and
angiotensin II (Ang H,) on cytosolic Ca2t at different hormone concen-
trations. Symbols are: (—•—) AVP + Ang II; (--0--) AVP; (—A—)
Ang II. These results, and those in the following figures, except Figure
2, correspond to x SEM of a minimum of five experiments at each
concentration. *D < 0.001 compared to the response to AVP or Ang II
alone; p < 0.05 compared to the sum of the responses to AVP and Ang
II.
LM). The extracts were applied to columns containing 1 ml of
Dowex-l (x8, Formate form) and serially eluted with 2 ml
aliquots of CH7O, Borax (5 ma disodium tetraborate, 60 mM
sodium formate), 0.2, 0.5, and 1.0 M ammonium formate (in 0.1
M formic acid) separating, respectively, inositol, glycero-phos-
phatidylinostol, inositol-l -phosphate, inositol bisphosphate,
and inositol trisphosphate (1P3); this last fraction includes 1,3,4-
and l,4,5-1P3 and l,3,4,5-inositol phosphate. Samples were
collected and counted in a scintillation counter. The extraction
procedure has been previously validated in this laboratory with
radioactive phosphoinositides. Results were expressed as num-
ber of 1P3 counts per milligram of protein. In all the experi-
ments, where needed, protein concentrations were measured
by the method of Lowry et al [21].
Statistical analysis
Two-way analysis of variance, unpaired Student's t-test and
chi square on '2 x 2" tables were used for statistical compar-
isons. A P value of less than 0.05 was considered significant.
Results
Intracellular free Ca2
The basal value for [Ca2]1 measured by the fura2 method
was 86.5 24.0 flM (N = 120). The concentration-response
pattern of the VSMC [Ca2] levels in the presence of AVP and
Ang II alone or in the presence of an equimolar combination of
both hormones is shown in Figure 1. At submaximal concen-
trations, that is, between 10_b and 10—8 M, the combination of
AVP and Ang II increased [Ca2]1 at a level more than additive
compared to the separate effect of each hormone (Fig. 1).
However, at iO— M the effect of the two hormones was additive
and at lO_6 M the effect of the two hormones added together
was less than additive (Fig. 1). A similar potentiation, albeit at
slightly reduced [Ca2] values, was observed when experi-
ments were carried out in medium without Ca2 and supple-
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Fig. 2. Time profile and shape of the cytosolic Ca2 curve with AVP
and Ang II added separately or together. Symbols are: (—•—) AVP
iO M + Ang II iO M; (—0—)AVP i0 M; (—A—) Ang II iO M.
This figure was constructed with the data from a representative exper-
iment.
mented with EGTA ([Ca2]1, AVP 10—8 M, 160.7 44.6; Ang II
10—8 M, 149.6 10.1; AVP 10—8 M + Ang 1110—8 M 536.2
89.9, N = 4). The time profile and the shape of the [Ca2]1
transient produced by the association of AVP + Ang II were
similar to that obtained with either hormone alone (Fig. 2). In
addition, no Ca2 mobilization was detected at concentrations
of 5 x 10—11 M of each hormone alone (subthreshold), whereas
the combination of the same concentration of AVP (5 x
M) and All (5 x 10 ' M) produced a detectable increase of
[Ca2]1 (50.3 5.1 M, N = 8).
45Ca2 + efflux
The effect of various concentrations of AVP and All alone
and combined are depicted in Figure 3. A similar pattern of
response as that observed in the fura2 experiments was also
found in the 45Ca2 efflux experiments, in the range between
i0 to lO—'° M. The total amount of releasable 45Ca2 de-
creased proportionally to the amount of 45Ca2 released by the
hormones. Subthreshold doses of the two hormones (5 x 101
M) administered simultaneously produced an increase in 45Ca2
efflux (12.4 0.9 counts/total counts 1) which was not present
when each hormone was administered separately. A subthresh-
old concentration of Ang II (5 x 10—11 M) also produced a
leftward shift of the Ca2 efflux concentration-response curve
of AVP (Fig. 4).
VSMC shape change
The combination of AVP + Ang II produced an increased
percent of shape change of VSMC as compared with the effect
of either hormone alone (Fig. 5), which was more marked at
10b0 and 10—8 M. The combination of both hormones at a
concentration of 5 x lO M elicited a shape change of 8.10
0.7% of the VSMC, whereas either AVP or Ang II alone at 5 x
10h1 M did not provoke a cell shape change different from the
spontaneous (AVP 3.4 1.8 + Ang 113.2 1.6% of the VSMC,
both P < 0.005, compared to the two hormones added togeth-
er).
Receptor binding
No differences in the amount of specific receptor binding of
AVP were found by incubating the cells in the presence of 10—8
M Ang II (Fig. 6) and 2 x 10-8 M (data not shown). The
concentrations of the hormones are detailed in the legend of the
figure. Changes in Ang II binding were also not found when the
binding experiments were done in the presence of 2 x io (N
= 4) and 10—8 M AVP (N = 4) (95.09 10.4 and 93.6 9.3% of
the specific binding, respectively, NS).
Production of inositol phosphates
As shown in Figure 7, the values of 1P2 and 1P3 were
increased in an additive manner by the combination of the two
hormones at l0— M. No changes in 1P1 levels were detected by
the action of the hormones at the time (15 sec) used for the
incubations (10 M AVP, 24735 2557; i0 M Ang II, 27081
1332; i0 M AVP + i0 M Ang II, 27383 1970; basal
22463 3950 cpm/mg prot', NS). A similar additive effect of
the combination of the two hormones was found at a lower
concentration of the hormones, since 108 M AVP produced an
increase of 1P3 over the basal (cpm . mg prot') of 580 252,
108 M Ang II, 452 294 and both together 1173 634.
Discussion
The present study examined the interaction of two vasoactive
hormones, AVP and Ang II, at the cellular level in VSMC. The
effect of such pressor agonists on vascular tissue could be
competitive, thus a diminution in their vascular effects would
occur when the hormones are administered simultaneously.
Alternatively, an additive or synergistic effect might occur in
the same circumstance. The present results provide evidence
that in cultured VSMC a potentiating effect between AVP and
Ang II occurs on cellular Ca2 mobilization, as assessed by the
changes in [Ca2], levels and Ca2 efflux. Evidence for that
positive interaction between AVP and Ang II included: 1) the
increase in the [Ca2]1 transient by the simultaneous adminis-
tration of both hormones at submaximal concentrations was
more than the sum of that of either hormone alone; 2) a Ca2
mobilizing response was observed with the simultaneous ad-
ministration of subthreshold concentrations of the two hor-
mones; and 3) the enhanced effect on the AVP-mediated Ca2
efflux was observed with a subthreshold concentration of Ang
II. At maximal AVP concentrations (10—6 M), however, the
potentiating effect was no longer present; most likely, this
observation may be due to the exhaustion of releasable intra-
cellular Ca2 stores (Fig. 3, inset). The results of the experi-
ments performed in medium without extracellular Ca2 demon-
strate that the interaction between AVP and Ang II probably
involves Ca2 release from intracellular stores and suggests
that an increase in Ca2 uptake is not the primary mechanism of
the increased rapid Ca2 mobilization. Moreover, Takeda et al
[22] have demonstrated that dantrolene, a blocker of Ca2
release from the endoplasmic reticulum, abolishes the Ca2
transient in response to pressor hormones such as AVP. How-
ever, an interaction between the hormones on Ca2 uptake at a
later time cannot be excluded by the present experiments. In
this regard, synergistic interactions between glucagon and Ca2
mobilizing agents on a Ca2 influx pathway have been found in
perfused rat liver [23—25].
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Fig. 4. Leftward shifting of the 45Ca2 efflux AVP concentration
response curve in the presence of a subthreshold (5 X 10" M)
concentration of Ang II. Symbols are: (.-O--) AVP; (—----) AVP +
Ang 11(5 x 10" M). * < 0.001.
On the basis of the current knowledge of the pathways
leading to vascular smooth muscle contraction, several possible
cellular sites have to be considered in the analysis of the cellular
interaction of AVP and Ang II. AVP and Ang II may interact at
a receptor level; specifically, one hormone might modify the
number of binding sites or the affinity of the receptors for the
other hormone. However, the positive interaction observed
between the two hormones at near maximal binding concentra-
tions, that is, 100 times or more higher than the Kd (nM) of their
respective receptors, is difficult to explain by an effect at the
receptor level. Moreover, in the experiments assessing cellular
Ca2 changes, in which both hormones were added simulta-
neously, a more rapid onset (15 sec) was observed than would
be expected by interactions at the receptor level. The experi-
mental results of the binding experiments also provided evi-
dence that the potentiated Ca2 peak was not due to increased
hormone binding. However, further experiments, that is, Scat-
chard analysis for each hormone in the presence of the other
hormone, will be necessary to clarify whether there is "cross-
talk" between the binding sites, perhaps as mediated by an
effect of signal processing.
A post-receptor interaction between AVP and All could
involve inositol phosphates production. 1P3 would then act as a
messenger to stimulate Ca2 release from the endoplasmic
reticulum [10—12]. Our results demonstrate that, at an early time
of activation (15 sec), the combination of the two pressor
hormones is additive for both 1P3 and 1P2. Nabika eta! [25] have
also found an additive increase in inositol phosphatides produc-
tion by VSMC simultaneously challenged with AVP and Ang II.
However, these authors did not find changes in 1P3 at one
minute after the administration of AVP alone. This difference in
1P3 results is probably due to the short duration of the IP3 peak;
specifically, this 1P3 peak may no longer be detectable 30 to 45
seconds after the hormone stimulation. This time is simulta-
neous with the Ca2 release from the intracellular stores.
The fact that AVP and Ang II at subniaximal concentrations
interact on [Ca2]1 mobilization and 1P3 production in a non-
competitive manner is therefore suggestive that the binding of
each hormone to its specific receptor stimulated production of
IP3 from separate sources, for example, different subunits of
phospholipase C or different membrane phospholipid mole-
cules. Hypothetically, this would provoke the breakdown of
different PIP2 molecules and probably release Ca2 from inde-
pendent subunits of the same ionomycin-releasable store. This
interpretation is consonant with evidence showing that the PIP2
pool available for 1P3 formation is compartmentalized; thus,
only part of the total PIP2 pool may be available to each
separate receptor [15].
Since at submaximal concentrations the two hormones added
together released more Ca2 than the sum of the Ca2 released
by each hormone added alone, a second mechanism of hormone
interaction may be operative. Specifically, an increased 1P3-
mediated release of Ca2 from intracellular stores may occur.
The experiments showing that subthreshold concentrations of
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Fig. 3. Effect of the combination of threshold
concentrations of AVP and Ang I! on 4SCa2+ efflux.
Symbols are: (--0--) AVP; (—A—) Ang 11; (—•—)
AVP + Ang II. Inset. Amount of ionomycin-
releasable 45Ca2 remaining in the cells at 4 mm
after the application of the hormones. *p < 0.001
compared to the response to AVP or Ang II alone;p < 0.05 compared to the sum of the responses to
AVP and Ang II.
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one of the hormones provoked a leftward shift of the 45Ca2
release by the other hormone, and that the association of two
subthreshold concentrations resulted in a threshold effect dem-
onstrates that a measurable increase in [Ca2] by one of the
hormones is not necessary for it to potentiate the Ca2 mobi-
lizing effect of the other hormone. Ware, Smith and Salzman
[261 have also found that a simultaneously elevated cytosolic
Ca2 is not necessary for the synergistic interaction between
platelet aggregating mediators to occur. Ca2 release from
intracellular stores has been shown to be a complex phenome-
non, probably involving interactions between 1P3 and GTP
[27—29], cyclic nucleotides [14, 30], and phosphorylation of
proteins of the endoplasmic reticulum which are involved in
Fig. 5. Vascular smooth muscle shape
change in the presence of ddferent
concentrations of separate or combined AVP
and Ang II. Symbols are: (0) AVP; () Ang
II; (U) AVP + Ang 11. < 0.001 compared
to the response to AVP or Ang II alone. Each
column corresponds to a minimum of 45 cells
in three or more separate experiments.
Ca2 transport [16]. The association of Ca2 containing endo-
plasmic reticulum vesicles with a membrane receptor-related
domain may also be important in modulating the amount of
Ca2 release [31] by increasing the availability or sensitivity of
the intracellular Ca2 stores to the action of the Ca2 releasing
mediators, namely 1P3 and GTP. An interaction between the
two hormones on the production of prostaglandins, that is,
PGE2, affecting Ca2 turnover is also theoretically possible and
cannot be ruled out from the present results. Thus, the inter-
action between AVP and Ang II to provoke an increased Ca2
releasing response may involve one or more of the aforemen-
tioned mechanisms.
A functional correlation of the AVP and Ang II interaction on
the Ca2 releasing mechanism was also provided by the results
of the VSMC shape change experiments. These results are
consistent with results in in vivo experiments [7] and in isolated
vessel preparations [8]. However, the shape change experi-
ments suggest that, especially at hormone concentrations
higher than io' M, there may not be a full correspondence
between the increase in Ca2 mobilization by the combined
AVP and Ang II and the shape change response. Also, it should
be emphasized that the present results at the cellular level
cannot be automatically generalized to the actual in vivo
conditions in humans or experimental animals.
Lastly, it should be emphasized that there are important
pathophysiological implications from this positive interaction
between pressor hormones, since AVP, Ang II and the sympa-
thetic nervous system are simultaneously activated in a number
of clinical circumstances [1]. As recently found by Arnolda et a!
[32] in a rabbit model of congestive heart failure and by
Zimmerman, Robertson and Jackson [33] in a model of reno-
vascular hypertension, lower degrees of activation of combined
pressor systems may be more efficacious in maintaining arterial
pressure or eliciting a vasoconstrictive response than higher
degrees of stimulation of any single pressor system. The present
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Fig. 6. Absence of changes in total and specUic receptor binding of
AVF in the presence of Ang II. Symbols are: (0) specific binding; ()
non-specific binding. Labeled AVP concentration 2 x lO M; Ang II
concentration 10—8 M.
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Fig. 7. Effect of AVP and Ang ii on
production of inositol phosphates, 15 sec after
the hormones application. Symbols are: (D)
basal; () Ang II i0 M; () AVP i0 M;() AVP l0 M + Ang H i0 M. *D < 0.001
compared to basal. P < 0.001 compared to
AVP or Ang II alone. The P value was not
significant between the sum of the 1P2 or 1P3
values in the presence of AVP alone and Ang
II alone and the 1P2 or 1P3 values in the
'I'2 1P3 1P2 P3 1P2 ip3 ip2 p3 presence of both hormones added together.
results thus emphasize the importance of considering not only
the effect of each separate pressor agent, but also the potential
interaction of such mediators on vascular smooth muscle con-
traction. One mechanism of this interaction appears to occur at
a post-receptor site and involve increased Ca2 release from
intracellular stores.
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